Literature DB >> 11897423

Design of Peumus boldus tablets by direct compression using a novel dry plant extract.

Santiago Palma1, Claudia Luján, Juan Manuel Llabot, Gloria Barboza, Ruben Hilario Manzo, Daniel Alberto Allemandi.   

Abstract

A solid pharmaceutical dosage formulation using a novel dry plant extract of Peumus boldus MOL. (Monimiaceae) (Pb) is proposed. The botanical evaluation of plant material, through morphological and anatomical diagnosis, is presented. This evaluation permits to identify the herb to be used correctly. The analysis of the most extractive solvent mixture and the attainment of plant extract (fluid and dry) are reported. Several formulations (tablets) containing a novel dry plant extract of Pb and common excipients for direct compression are evaluated. The following formulation: dry plant extract of Pb (170 mg), Avicel PH101 (112 mg), Lactose CD (112) and magnesium stearate (6 mg), compressed at 1000 mPa, showed the best pharmaceutical performance.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11897423     DOI: 10.1016/s0378-5173(01)00940-1

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  3 in total

1.  Mucoadhesive bilayered tablets for buccal sustained release of flurbiprofen.

Authors:  Luana Perioli; Valeria Ambrogi; Stefano Giovagnoli; Maurizio Ricci; Paolo Blasi; Carlo Rossi
Journal:  AAPS PharmSciTech       Date:  2007-07-13       Impact factor: 3.246

2.  Valeriana officinalis Dry Plant Extract for Direct Compression: Preparation and Characterization.

Authors:  Loreana Gallo; María Veronica Ramírez-Rigo; Juliana Piña; Santiago Palma; Daniel Allemandi; Verónica Bucalá
Journal:  Sci Pharm       Date:  2012-07-12

3.  Development strategies for herbal products reducing the influence of natural variance in dry mass on tableting properties and tablet characteristics.

Authors:  Ylber Qusaj; Andreas Leng; Firas Alshihabi; Blerim Krasniqi; Thierry Vandamme
Journal:  Pharmaceutics       Date:  2012-10-08       Impact factor: 6.321

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.